Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years,
making it a $6B industry by 2022. These often in-vitro medical devices provide essential information for the efficacy of a corresponding drug or biological product, and are also used for pre-determining the efficacy of treatment. In this webinar recording our presenters will take a look across
key trends for both device and drug companies and deliver insights to support your deal-making activities, help you manage risk, and help you spot new opportunities.